Search

everythingexperts & clinicslearnresearchcommunity

for

Search:↓

Certain genetic variations in the SHBG gene are linked to an increased or decreased risk of PCOS in Mediterranean women.

Testosterone and DHEA can benefit women's health but must be prescribed carefully due to potential risks.

Isotretinoin improves severe acne without changing androgen or insulin levels but may increase body weight and triglycerides.

The L457(3.43)R mutation in the human lutropin receptor causes increased activity and hormone insensitivity, leading to precocious puberty.

A certain genetic variation is linked to a higher risk of polycystic ovarian syndrome.

Women with PCOS had higher SRAGE levels, possibly linked to BMI, not PCOS.

Human scalp hair follicles have PGE2 and its receptors, which might affect hair growth.

Eph receptors and ephrins may be promising targets for treating diseases, but more understanding is needed for effective and safe therapies.

Women with myotonic dystrophy might get diseases related to male hormones because their body tissues are extra sensitive to these hormones.

Androgens increase growth factors in skin cells, which may lead to acne.

AKR1D1 controls glucocorticoid levels and receptor activity in liver cells.

Creating stronger blockers for skin enzymes might lead to better treatment for conditions like acne and excessive hair growth.

Different women's hair and skin glands respond to hormones in varied ways, which can cause unwanted hair growth even with normal hormone levels, and more research is needed to treat this effectively.

Blocking the prolactin receptor might help treat various diseases, but more research is needed.

Androgen therapy might help some women with low libido, but it has risks and should be used carefully.

Cedrol may help reduce liver fat and fat cell growth caused by corticosteroids.

The vitamin D receptor has many roles in the body beyond managing calcium, affecting the immune system, hair growth, muscles, fat, bone marrow, and cancer cells.

The report concludes that PCOS is mainly a condition of excess male hormones and its definition may change as new information is discovered.

Experts recommend using evidence-based methods to diagnose and treat hirsutism, focusing on symptoms and underlying causes.

The Endocrine Society advised against routine testosterone therapy for women, citing a need for more research on long-term safety and a clear definition of androgen deficiency.

Androgens block hair growth by disrupting cell signals; targeting GSK-3 may help treat hair loss.

The conclusion is that managing androgen excess requires long-term treatment, including hormonal contraceptives and androgen blockers, with follow-up after six months.

Androgens play a role in female sexual function, and testosterone therapy can help women with low sexual desire, but more research is needed on treatments and long-term safety.

Overexpressing the mineralocorticoid receptor in mouse skin causes skin thinning, early skin barrier development, eye issues, and hair loss.

Androgens cause skin issues like acne and hair growth in women, often due to PCOS, and can be treated with medication and lifestyle changes.

PPAR agonists show promise for skin conditions but need more research before being a main treatment.

Androgen conjugates might be better indicators of skin sensitivity to hormones in women with excessive hair growth.

Use "female pattern hair loss" term, assess androgen excess, treat with minoxidil and other medications if needed.

Androgen Deprivation Therapy for prostate cancer often reduces sexual function but intermittent therapy may be more tolerable.

Hair loss in women not always linked to increased oil production; other factors may be involved.